Pharma Friday – Sept. 11, 2026

Published on September 11, 2026

An Endocrine News roundup of the week’s pharmaceutical news, breakthroughs, and general information. * Moonwalk Biosciences Announces $70 Million Series B Financing to Advance Adipose-Targeted RNAi Therapies for Obesity and Cardiometabolic Diseases On Sept. 8, Moonwalk Biosciences, a biotechnology company developing adipose-targeted RNA interference (RNAi) medicines for obesity and cardiometabolic diseases, announced the closing of […]

The post Pharma Friday – Sept. 11, 2026 appeared first on Endocrine News.

Continue reading on website
Other news

Minding the Gaps: What Happens When Pediatric Patients with Pituitary Tumors Become Adults?

September 10, 2026
Endocrine News speaks to Kevin C. J. Yuen, MD, FRCP, FEAA (above, left) about his ENDO 2026 Meet-the-Professor session titled “Pituitary Tumor Survivorship: Transitioning from Pediatric to Adult Endocrine Care” in which he detailed the often-complicated shift for these patients and their clinicians. Challenging though it can be, he says guidance is available, but it […]The post Minding the Gaps: W